Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 63

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 1
Chunk 63
---
 the Company
is presented below:

    Level 1  
    Level 2  
    Level 3  
    Total 
  
    Preferred stock warrant liability (Predecessor): 

    Balance at December 31, 2023 
    $-  
    $-  
    $320,117  
     320,117 
  
    Reclassification of warrant liability to equity 
     -  
     -  
     (320,117) 
     (320,117)
  
    Balance at February 13, 2024 
    $-  
    $-  
    $-  
    $- 

    Earnout liability (Successor): 

    Balance at March 31, 2024 
    $-  
    $-  
    $3,100,000  
    $3,100,000 
  
    Gain on revaluation of earnout liability 
     -  
     -  
     (2,900,000) 
     (2,900,000)
  
    Balance at June 30, 2024 
    $-  
    $-  
    $200,000  
    $200,000 

    Earnout liability (Successor): 

    Balance at February 14, 2024 
    $-  
    $-  
    $4,900,000  
    $4,900,000 
  
    Gain on revaluation of earnout liability 
     -  
     -  
     (4,700,000) 
     (4,700,000)
  
    Balance at June 30, 2024 
    $-  
    $-  
    $200,000  
    $200,000 
  
    Earnout liability (Successor): 

    Balance at December 31, 2024 
    $-  
    $-  
    $20,000  
    $20,000 
  
    Gain on revaluation of earnout liability 
     -  
     -  
     -  
     - 
  
    Balance at June 30, 2025 (1) 
    $-  
    $-  
    $20,000  
    $20,000 

(1)There was no change in